Estrogen receptors in patients with malignant melanoma

Edward T. Creagan, James N. Ingle, John E. Woods, Douglas J. Pritchard, Nai‐Siang ‐S Jiang

Research output: Contribution to journalArticlepeer-review

37 Scopus citations


We detected cytoplasmic estrogen receptors (ER) in only 4 of 34 (12%) patients with malignant melanoma. The titers as assayed by the dextran‐coated charcoal method were 3, 3, 4, and 5 fmol/mg, respectively. Our data indicate that the incidence of melanoma with detectable ER is low, which suggests that any potential clinical usefulness of the ER assay in melanoma might be limited.

Original languageEnglish (US)
Pages (from-to)1785-1786
Number of pages2
Issue number8
StatePublished - Oct 15 1980

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Estrogen receptors in patients with malignant melanoma'. Together they form a unique fingerprint.

Cite this